FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 20 filers reported holding FREELINE THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $86,233 | -5.2% | 189,503 | -1.0% | 0.00% | – |
| Q4 2022 | $90,936 | -24.8% | 191,403 | +10.5% | 0.00% | – |
| Q3 2022 | $121,000 | -28.0% | 173,145 | -10.3% | 0.00% | – |
| Q2 2022 | $168,000 | -18.8% | 192,943 | +4.4% | 0.00% | – |
| Q1 2022 | $207,000 | -1.9% | 184,730 | +73.4% | 0.00% | – |
| Q4 2021 | $211,000 | +49.6% | 106,525 | +157.7% | 0.00% | – |
| Q3 2021 | $141,000 | -48.5% | 41,341 | +22.9% | 0.00% | – |
| Q2 2021 | $274,000 | -0.4% | 33,637 | +50.7% | 0.00% | – |
| Q1 2021 | $275,000 | -43.9% | 22,323 | -16.9% | 0.00% | – |
| Q4 2020 | $490,000 | +137.9% | 26,859 | +103.4% | 0.00% | – |
| Q3 2020 | $206,000 | – | 13,206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,997,620 | $19,307,000 | 27.43% |
| CHI Advisors LLC | 4,862,319 | $4,230,000 | 1.62% |
| TFG Asset Management GP Ltd | 3,760,508 | $3,272,000 | 0.22% |
| Eventide Asset Management | 5,950,000 | $5,168,000 | 0.11% |
| HARBOR CAPITAL ADVISORS, INC. | 146,562 | $129,000 | 0.10% |
| Values First Advisors, Inc. | 56,300 | $49,000 | 0.04% |
| MORGAN STANLEY | 192,943 | $168,000 | 0.00% |
| SG Americas Securities, LLC | 51,663 | $45,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 26,963 | $23,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 34,786 | $31,000 | 0.00% |